Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Coherus Bio (CHRS)

Coherus Bio (CHRS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,297,708
  • Shares Outstanding, K 70,913
  • Annual Sales, $ 356,070 K
  • Annual Income, $ 89,830 K
  • 60-Month Beta 2.10
  • Price/Sales 3.63
  • Price/Cash Flow 13.75
  • Price/Book 8.25
  • Price/Earnings ttm 9.03
  • Earnings Per Share ttm 2.02
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/06/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 0.26
  • Number of Estimates 4
  • High Estimate 0.33
  • Low Estimate 0.20
  • Prior Year 0.32
  • Growth Rate Est. (year over year) -18.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.57 +17.53%
on 06/15/20
19.65 -6.87%
on 06/03/20
-0.86 (-4.49%)
since 06/02/20
3-Month
14.12 +29.60%
on 04/15/20
19.72 -7.20%
on 05/27/20
+3.34 (+22.33%)
since 04/02/20
52-Week
10.86 +68.48%
on 03/18/20
23.91 -23.46%
on 09/25/19
-4.66 (-20.30%)
since 07/02/19

Most Recent Stories

More News
SmarTrend Watching for Potential Pullback in Shares of Coherus Bioscien After 1.82% Gain

Coherus Bioscien (NASDAQ:CHRS) traded in a range yesterday that spanned from a low of $17.62 to a high of $18.02. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high...

CHRS : 18.30 (+0.27%)
Coherus BioSciences Announces New Employment Inducement Grants

Coherus BioSciences, Inc. ("Coherus" or the "Company", Nasdaq: CHRS), today announced that effective June 18, 2020, the compensation committee of the Company's board of directors granted options to purchase...

CHRS : 18.30 (+0.27%)
Essent Group Set to Join S&P MidCap 400; Coherus BioSciences, Patterson-UTI Energy to Join S&P SmallCap 600

, /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 effective prior to the open of trading on :

CHRS : 18.30 (+0.27%)
ESNT : 34.52 (+0.26%)
NE : 0.2994 (-0.63%)
OPB : 19.49 (-2.35%)
PPBI : 20.20 (-0.15%)
PTEN : 3.36 (+3.23%)
SPGI : 333.25 (-0.38%)
10.8% Return Seen to Date on SmarTrend Coherus Bioscien Call (CHRS)

SmarTrend identified an Uptrend for Coherus Bioscien (NASDAQ:CHRS) on March 24th, 2020 at $15.00. In approximately 2 months, Coherus Bioscien has returned 10.80% as of today's recent price of $16.62.

CHRS : 18.30 (+0.27%)
Coherus BioSciences Reports First Quarter 2020 Financial Results

- First Quarter UDENYCA(R) Net Sales of $116.2 Million -

CHRS : 18.30 (+0.27%)
Shares of CHRS Up 6.1% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Coherus Bioscien (NASDAQ:CHRS) on March 24th, 2020 at $15.00. In approximately 1 month, Coherus Bioscien has returned 6.13% as of today's recent price of $15.92.

CHRS : 18.30 (+0.27%)
Coherus BioSciences Management to Present at BofA Securities 2020 Health Care Conference

Coherus BioSciences, Inc. ("Coherus", Nasdaq: CHRS), today announced that senior management will make a virtual presentation at BofA Securities 2020 Health Care Conference on Thursday, May 14, 2020 at...

CHRS : 18.30 (+0.27%)
Coherus BioSciences (CHRS) Earnings Expected to Grow: Should You Buy?

Coherus BioSciences (CHRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CHRS : 18.30 (+0.27%)
Coherus BioSciences to Report First Quarter Financial Results on May 7th

Coherus BioSciences, Inc. ("Coherus" or the "Company", Nasdaq: CHRS), today announced that its first quarter 2020 financial results will be released after market close on Thursday, May 7, 2020. Starting...

CHRS : 18.30 (+0.27%)
Watch for Coherus Bioscien to Potentially Pullback After Gaining 5.41% Yesterday

Coherus Bioscien (NASDAQ:CHRS) traded in a range yesterday that spanned from a low of $15.22 to a high of $16.49. Yesterday, the shares gained 5.4%, which took the trading range above the 3-day high...

CHRS : 18.30 (+0.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade CHRS with:

Business Summary

Coherus Biosciences, Inc. is a biologics platform company developing biosimilar therapeutics. Its clinical stage pipeline consists of CHS-0214 in two Phase III clinical trials for the treatment of rheumatoid arthritis and psoriasis; CHS-1420 that has completed a Phase I study to treat psoriasis or rheumatoid...

See More

Key Turning Points

2nd Resistance Point 18.92
1st Resistance Point 18.61
Last Price 18.30
1st Support Level 18.10
2nd Support Level 17.90

See More

52-Week High 23.91
Fibonacci 61.8% 18.93
Last Price 18.30
Fibonacci 50% 17.39
Fibonacci 38.2% 15.85
52-Week Low 10.86

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar